disruptions is the sole category represented across all 1 tracked stories. EMA is most often covered alongside FDA, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Supply Chain story that mention EMA, all published on March 4, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about EMA
disruptions is the sole category represented across all 1 tracked stories. EMA is most often covered alongside FDA, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Supply Chain story that mention EMA, all published on March 4, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering EMA. Shared-story counts are live from our verified record — not editorial picks.
Escalating military conflict involving Iran has severely compromised critical maritime trade routes, threatening the global supply of pharmaceutical precursors. Analysts warn that prolonged instability will lead to significant price increases for essential medications as logistics costs and insurance premiums soar.